Work

259 Phase II trial of recombinant interleukin-4 (IL-4 SCH 39400) in advanced non-small cell lung cancer (NSCLC); a dose ranging study

Year: 1997

Type: article

Source: Lung Cancer

DOI: 10.1016/s0169-5002(97)89640-7

Authors: M.R. Modiano, S. Burdette-Radoux, U. Gatzemeier, R.A. Figlin, S. Aamdal, J. Crawford, M. Kies, M.E. Rybak

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2009119250

FWCI:

Cites:

Cited by:

Related to: 10